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noticeabledecrease in thenumberof shigellosis caseswasobserved
and subsequent water testing on 10 December 2012 showed no E.
coli.
Conclusion: The sudden unprecedented increase in Shigella
cases was likely due to contaminated potable water exposure
and additional secondary cases. The investigation highlighted the
necessity for continual monitoring of potable water quality and
prompt corrective action tomaintain a safewater supply in the dis-
trict. Theefﬁcient, timelyoutbreak response resulted inappropriate
public health interventions and underscores the value of a well-
functioning DORT and NOU-DORT collaboration within the South
African public health context.
http://dx.doi.org/10.1016/j.ijid.2014.03.927
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Background: There has been no consensus on the ideal way
to measure adherence in resource limited settings (RLS). Viral
load is perhaps the most reliable indicator of poor adherence
but is not easily accessible in RLS. We aimed to identify rou-
tinely collected markers that could be used to assess adherence
to ART.
Methods & Materials: Retrospective analysis of HIV-positive
ART-naïve adults (≥18 years) initiating standard ﬁrst-line ART at
the Themba Lethu Clinic in Johannesburg, South Africa between
April 2004 and January 2012. We assessed the association between
the last self-reported adherences, change in mean cell volume
(MCV) calculated from baseline to 6 months, change in CD4 count
calculated from baseline to 6 months and missed visits and poor
adherence (deﬁned as a viral load ≥400 copies/ml after 6 months
onART). Poisson regressionmodelswith robust error variancewere
constructed to estimate incidence rate ratio (IRR) and 95% conﬁ-
dence interval (CI). The IRR was used to approximate the relative
risk (RR) of poor adherence.
Results: A total of 7160 patients were eligible for the study. Of
these, 18.9% had poor adherence at 6 months. The marker of poor
adherence was change in CD4 count stratiﬁed by change in MCV at
6 months (change in CD4 ≥expected and change in MCV <14.5fL;
Attributable risk ratio (aRR) 3.11, 95% CI 2.41-4.02, change in CD4
<expected and change in MCV ≥14.5fL; aRR 1.23 95% CI 0.76-2.00
and change in CD4 <expected and change in MCV <14.5fL; aRR 6.98
95% CI 5.35-9.09).
Conclusion: The CD4 cell count stratiﬁed by change in MCV at
6 months was identiﬁed as a predictor of poor adherence to ART.
This ﬁnding could help health workers identify and manage poor
adherence to ART in the absence of viral load testing. Further stud-
ies are needed to determine whether this predictor remains useful
beyond 6 months of ART medication as the number of patients on
tenofovir (TDF)-based regimens increases.
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Background: Incidence of Enteric fever in Dhaka (2005) was
3.9/ 1,000 population/ year. It decreased in 2010, still it is high.
Now no surveillance at national level. Hospital based surveil-
lance undertaken to determine: number of febrile cases positive
for enteric fever; antibody against salmonella, i.e., S. typhi & S.
paratyphi A, B; antimicrobial sensitivity pattern of the isolated
organism; estimate the age speciﬁc occurrence of enteric fever
and high risk groups identiﬁcation; assess socio demographical
characteristics.
Methods & Materials: Surveillance covered two rural and
three urban hospitals. Case-patients had axillary temperature >38◦
C/100◦F for >3 consecutive days, taken no antibiotic, enrolled every
2 days/ week. Socio-demographical, epidemiological data and 7ml
(5ml from ≤ 12 years) of venous blood was collected Oct 2009 -
May2011.Widal tubeagglutination testwasperformed, usingplas-
matic reagents (Plasmatec Laboratory Products), containing O and
Hantigens of S. Typhi, S. Paratyphi A&B. Positive andnegative serum
controls were included, a titre of >1:80 and >1:160 to either anti-
gen in a single serum specimen was taken as indicative of enteric
fever. Salmonella typhi O and H. agglutinin titres >1:80 and >1:160
were takenas signiﬁcant (88%sensitivity and98%speciﬁcity). Lyzed
blood from AISBACT inoculated into solid media, McConkey agar
and selective media, Salmonella and Shigellae agar and incubated
aerobically 37◦C for 18hours.
Results: In 2015 patients, male 55.2%, 49.4% (n=996) detected
as enteric fever by Widal test and/or blood culture, typhoid 76.3%
(n=103)bybloodculture,while92.7% (n=874)byWidal test. Paraty-
phoid a 5.6% (n=53), Paratyphoid b 1.7% (n=16) by Widal test;
Paratyphoid a 23.7% (n=32) by culture.
Blood culture showed Ceftriaxone (90.4%), Ciproﬂoxacin
(88.9%), and Ceftazidime (86.7%) sensitivity; 95.3% resistant to Cot-
rimoxazole; Among patients 39.8% typhoid and 28.1% paratyphoid
A were multidrug resistant (MDR).More (10-55 cases/ week) cases
in early summer (2nd week of March to 1st week of July 2010);
84.5% (n=114) patients were 13-59 years. No signiﬁcant difference
between drinking water from different sources for having enteric
fever.
